Cracking the Enigma of Adenomyosis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".
Deadline for manuscript submissions: closed (20 November 2022) | Viewed by 27217
Special Issue Editor
2. Laboratory of Female Reproductive Endocrine-Related Diseases, Fudan University, Shanghai, China
Interests: endometriosis; adenomyosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Adenomyosis is a common gynecological disease with an enigmatic pathogenesis and pathophysiology. Despite its high prevalence and negative impact on the quality of life in women with adenomyosis, it is an under-funded and under-investigated disease, with a total number of PubMed-indexed publications less than 1% of that on breast cancer. As a result, its clinical management poses a big challenge.
In the last 5-6 years, the landscape for clinical management of adenomyosis has been changing rapidly. The use of dienogest, the approval of GnRH antagonists, the advent of revolutionary surgical procedures, and various ablation methods—high-intensity focused ultrasound (HiFu), radiofrequency, and microwave, and the experimental demonstration that iatrogenic uterine procedures can increase the risk of development of adenomyosis. These have provided gynecologists with more options, but also produced areas of confusion.
It is time to take stock of these new developments and see how we can best use these new discoveries. In addition, knowledge gaps exist and should be identified. This Special Issue will invite leading experts on epidemiology, pathogenesis, pathophysiology, imaging diagnostics, surgery, and medical treatment to contribute to this Special Issue.
Prof. Dr. Sun-Wei Guo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adenomyosis
- diagnosis
- management
- pathogenesis
- pathophysiology
- surgery
Related Special Issue
- Cracking the Enigma of Endometriosis in Journal of Clinical Medicine (2 articles)